DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Intra-Cellular Therapies Inc. (ITCI)
« Back to company indexITCI Chatter Timeline
Stock Ticker for ITCI
Most Active Tweeters for ITCI
| User | Tweets |
|---|---|
| @AmericanBanking | 4 |
| @TickerReport | 4 |
| @stocknewstimes | 4 |
| @Tickeron | 3 |
| @TranscriptDaily | 3 |
Recent Tweets for ITCI
 |
@WeekHerald Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/aFhboKGchc September 14th 2019, 7:09pm |
 |
@OlympiaReport Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/7GzrfPsGTe September 14th 2019, 7:09pm |
 |
@ThisLincolnian Intra-Cellular Therapies’ $ITCI “Buy” Rating Reaffirmed at Leerink Swann https://t.co/yl2V1MvvNb September 14th 2019, 7:09pm |
 |
@stocknewstimes Intra-Cellular Therapies $ITCI Given a $27.00 Price Target by Cantor Fitzgerald Analysts https://t.co/7rGxJ5GqKt September 14th 2019, 6:09pm |
 |
@ConsumerFeed Intra-Cellular Therapies $ITCI Given a $27.00 Price Target by Cantor Fitzgerald Analysts https://t.co/XdeAO7WDrS September 14th 2019, 6:09pm |
 |
@TickerReport Christopher D. Alafi Purchases 485,000 Shares of Intra-Cellular Therapies Inc $ITCI Stock https://t.co/sXNrI2GFoZ September 14th 2019, 4:09am |
 |
@Tickeron $ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other… https://t.co/mXYmddzUtj September 14th 2019, 2:09am |
|
@TickerReport Intra-Cellular Therapies $ITCI Earns Buy Rating from Leerink Swann https://t.co/JKrzaq027c September 13th 2019, 9:09pm |
|
@stocknewstimes JMP Securities Reiterates $21.00 Price Target for Intra-Cellular Therapies $ITCI https://t.co/SLVFtKW7l7 September 13th 2019, 11:09am |
 |
@TranscriptDaily Intra-Cellular Therapies $ITCI Given a $21.00 Price Target by JMP Securities Analysts https://t.co/hRIeSUyebK September 13th 2019, 11:09am |
 |
@dakotafinancial Intra-Cellular Therapies $ITCI Earns Buy Rating from Leerink Swann https://t.co/UCwyByp64R September 13th 2019, 11:09am |
|
@TickerReport JMP Securities Reiterates $21.00 Price Target for Intra-Cellular Therapies $ITCI https://t.co/GXFOE82MTw September 13th 2019, 11:09am |
 |
@ZolmaxNews Intra-Cellular Therapies $ITCI PT Set at $27.00 by Cantor Fitzgerald https://t.co/sEEOO0xw5i September 13th 2019, 11:09am |
|
@TickerReport Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/Pilc6pvNkG September 13th 2019, 11:09am |
 |
@dailypoliticaln Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/7TDUDEb8vO September 13th 2019, 10:09am |
 |
@aliontario Bought $itci for a swing September 13th 2019, 9:09am |
 |
@StockTexts $ITCI Intra-Cellular Therapies Inc. SEC Filing: Form EFFECT https://t.co/onAu8Ql3ff September 13th 2019, 6:09am |
 |
@confcalltran Intra-Cellular Therapies Just Received a Notice of Effectiveness https://t.co/Gx2dvgJTD9 $ITCI September 13th 2019, 6:09am |
|
@Tickeron $ITCI's price moved above its 50-day Moving Average on September 9, 2019. View odds for this and other indicators:… https://t.co/Qg77twFmmn September 12th 2019, 11:09pm |
 |
@newswelldone $ITCI: Intra-Cellular files $350M mixed shelf: https://t.co/AubRB89UVU September 12th 2019, 6:09pm |
 |
@LanderJesse RT @zbiotech: $ITCI files 350M mixed shelf https://t.co/b6MhvXlBMX September 12th 2019, 5:09pm |
 |
@Gambiste1 RT @MarketCurrents: $ITCI - Intra-Cellular files $350M mixed shelf https://t.co/InnmfHBQoF September 12th 2019, 5:09pm |
 |
@zbiotech $ITCI files 350M mixed shelf https://t.co/b6MhvXlBMX September 12th 2019, 5:09pm |
 |
@MarketCurrents $ITCI - Intra-Cellular files $350M mixed shelf https://t.co/InnmfHBQoF September 12th 2019, 5:09pm |
 |
@Stock_News_Now $ITCI: New SEC Filing for ITCI: Form 424B3 (No. 0001193125-19-243984): https://t.co/SxSY0UATP2 September 12th 2019, 5:09pm |
|
@confcalltran Intra-Cellular Therapies just filed a prospectus, suggesting it plans to soon issue some securi https://t.co/iYQKduMnru $ITCI September 12th 2019, 5:09pm |
 |
@pnani456 $ITCI H1 2-1-2 up / D1 3-1-2 up since the FDA no ADCOMM news #TheStrat https://t.co/mnA577qyNS September 12th 2019, 11:09am |
 |
@Sports_bios Two post X'mas PDUFAs - $ITCI 12/27 and $AMRN 12/28 - will they be actually post-X;mas remains to be seen.. could… https://t.co/KwEBAehH97 September 12th 2019, 7:09am |
 |
@AmericanBanking Cantor Fitzgerald Analysts Give Intra-Cellular Therapies $ITCI a $27.00 Price Target https://t.co/U7ysbovOdA #stocks September 12th 2019, 2:09am |
|
@AmericanBanking Intra-Cellular Therapies $ITCI Given a $21.00 Price Target by JMP Securities Analysts https://t.co/gyl3wtE734 #stocks September 12th 2019, 2:09am |
 |
@aistockfinder $ITCI https://t.co/iL1OxkZRfh Intra-Cellular_Therapies_Inc. This is a buy, this stock will probably move up. Hedge… https://t.co/71yB64HBXt September 12th 2019, 1:09am |
|
@Gambiste1 RT @Tickeron: $ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other indicators… September 12th 2019, 12:09am |
|
@Tickeron $ITCI's 10-day Moving Average broke below its 50-day Moving Average on July 10, 2019. View odds for this and other… https://t.co/2lVkvtBg0J September 12th 2019, 12:09am |
|
@AmericanBanking Intra-Cellular Therapies’ $ITCI “Buy” Rating Reaffirmed at Leerink Swann https://t.co/VKv4doCGKJ #stocks September 11th 2019, 11:09pm |
 |
@bbnsnews Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/NfVaaHENd7 September 11th 2019, 10:09pm |
|
@ThisLincolnian Intra-Cellular Therapies $ITCI Given a $21.00 Price Target at JMP Securities https://t.co/yzqpmLfBhP September 11th 2019, 10:09pm |
 |
@IRAMarketReport Intra-Cellular Therapies $ITCI Given a $27.00 Price Target at Cantor Fitzgerald https://t.co/zn7z02MZfF #markets September 11th 2019, 10:09pm |
 |
@chaffeybreeze Intra-Cellular Therapies $ITCI Given a $27.00 Price Target at Cantor Fitzgerald https://t.co/6L3t8ONdtf #stocks September 11th 2019, 10:09pm |
|
@ConsumerFeed Intra-Cellular Therapies $ITCI Given Buy Rating at Leerink Swann https://t.co/wAlEGzETey September 11th 2019, 10:09pm |
|
@IRAMarketReport Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/wW3omHycxH #markets September 11th 2019, 9:09pm |
|
@chaffeybreeze Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/TCQD7M69uG #stocks September 11th 2019, 9:09pm |
|
@dakotafinancial Cantor Fitzgerald Reiterates “$27.00” Price Target for Intra-Cellular Therapies $ITCI https://t.co/fGwIFxl48B September 11th 2019, 9:09pm |
 |
@WatchlistN Intra-Cellular Therapies $ITCI Rating Reiterated by Leerink Swann https://t.co/mAkInz6NFh September 11th 2019, 9:09pm |
|
@ZolmaxNews Intra-Cellular Therapies $ITCI PT Set at $21.00 by JMP Securities https://t.co/yi8RCePB1B September 11th 2019, 9:09pm |
|
@dailypoliticaln Intra-Cellular Therapies $ITCI PT Set at $21.00 by JMP Securities https://t.co/ammZNQmZCG September 11th 2019, 9:09pm |
|
@stocknewstimes Christopher D. Alafi Acquires 485,000 Shares of Intra-Cellular Therapies Inc $ITCI Stock https://t.co/9dXtH0OCnP September 11th 2019, 6:09pm |
|
@TranscriptDaily Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/ywgfaNBx3e September 11th 2019, 6:09pm |
 |
@TheMarketsDaily Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/9Oj5FC7DQk September 11th 2019, 6:09pm |
|
@AmericanBanking Intra-Cellular Therapies Inc $ITCI Director Christopher D. Alafi Buys 485,000 Shares https://t.co/nZRBhV8SFK #stocks September 11th 2019, 6:09pm |
|
@confcalltran Major owner of Intra-Cellular Therapies just picked up 485,000 shares https://t.co/QSfzyy5p8T $ITCI September 11th 2019, 4:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.